Latest Breaking News On - Axsome therapeutic auvelity - Page 1 : vimarsana.com

Relmada Therapeutics, Inc. has announced rapid and sustained effects of an anti-depressant in patients with major depressive disorders (MDD).

Philippa salterCedric ogormanSenior neurology analystRelmada therapeuticsAxsome therapeutic auvelityClinical developmentPreclinical researchAtient centricityPis active pharmaceutical ingredientsMajor depressive disorderAnti depressantClinical trialClinical studyClinical research